Loss of b-cell mass and function leads to the pathogenesis of type 1 and type 2 diabetes.
1
, that self-replication of pre-existing b-cells is the major mechanism for b-cell regeneration. Our knowledge of pancreatic b-cells would lead to a better understanding and manipulation of the maturation or proliferation of b-cells for regenerative medicine. Recently, Bader et al. 2 showed that b-cells can be divided into two populations, a proliferationcompetent population and mature bcells, marked by the expression of Fltp (also known as Flattop and Cfap126), a Wnt/planar cell polarity (PCP) effector. No glucose tolerance or insulin sensitivity phenotype was observed. However, glucose-stimulated insulin secretion (GSIS) was significantly decreased in isolated islets from Fltp knockout mice. In humans, the FLTP ortholog (CFAP126, also known as C1orf192) is associated with metabolic traits. sorted out human endocrine b-cell subpopulations according to the expression of these two antigens, and studied their gene expression profiles. These subpopulations are present in normal adult islets, and have diverse gene expression profiles, and distinct basal and GSIS. The b-cell distribution is markedly altered in type 2 diabetes, therefore raising the possibility that the b-cell subpopulations defined by these two antigens might be medically relevant. Unlike Bader et al.
2
, there are no lineage tracing data of these subpopulations, and therefore it remains to be determined whether conversion from one population to another occurs.
It has been under debate whether bcell regeneration from the stem cell pool occurs. Plasticity of the endocrine pancreas remains, so that transdifferentiation was reported to occur under certain conditions. Recently, dedifferentiation of bcells has been reported 
